Improve Your Decision Making With Actionable Pharma Insights
For those in the pharmaceutical industry, maintaining a competitive edge requires staying on top of regulatory activities, FDA drug approvals, drug development and clinical trials, and any potentially market-moving events. But regulatory sites like ClinicalTrials.gov are notoriously tedious and time-consuming to navigate, and in today’s age of information overload, finding the right insights becomes a herculean task.
Rather than relying on historical datasets and manually searching for information from fragmented sources, pharma professionals are turning to all-in-one market intelligence platforms, like AlphaSense, that have the capability of aggregating thousands of high-quality content sources.
With the AlphaSense platform, you can access exclusive content only found elsewhere in disparate locations and often locked behind expensive paywalls. This content includes:
- Healthcare news, industry reports, company reports, clinical trial updates and regulatory content from sources such as PubMed, ClinicalTrials.gov, World Health Organization, MedlinePlus, and FDA
- Over 1,500 research providers including Wall Street Insights®, a premier analyst research collection for corporate professionals
- Expert call transcript library with over 200,000 vetted interviews (including with competitors, suppliers, doctors, and KOLs)
Furthermore, the AlphaSense platform streamlines, accelerates, and simplifies your research process with advanced AI search technology. Gone are the days of manually parsing through high volumes of data, attempting to separate useful signals from the noise, and invariably leaving yourself susceptible to missed information or research blind spots.
With AI, you can quickly identify trends and patterns that would be impossible to detect using manual processes alone, thereby exponentially increasing the ROI of your research.
AlphaSense helps you quickly uncover precise insights on your competitors, drugmakers, the pharma industry, and the market at large — so that you can immediately incorporate them into your competitive strategy, R&D investment, and commercialization goals.
These features and more are why G2 has consistently rated AlphaSense a leader in market intelligence for corporations and financial institutions alike.
How the Top Pharma Companies Use AlphaSense
AlphaSense is trusted by the top 92% of life sciences organizations in the world, including pharmaceutical companies. Here’s how our clients utilize the platform to unlock critical insights:
Clinical Pipeline Tracking
In order to track the pharmaceutical pipeline, you need data from industry publications that provides reliable information about clinical trial developments. AlphaSense’s vast collection of regulatory content — which includes sources like ClinicalTrials.gov, FDA, EMA, PubMed, and more — enables clients to easily stay on top of any clinical trial updates and identify larger patterns in consumer demand and the market landscape.
Use our Generative Grid feature to make this process even more streamlined — simply ask our genAI to present clinical trial development data for your specific list of companies, and it will generate it in a dynamic, easy-to-read grid format that is updated automatically with any new developments.
Disease Landscaping
AlphaSense’s AI company recognition and Search Summaries help ensure you never miss out on key updates from pharma companies. With AlphaSense, you can extract data such as market share, pricing benchmarks, M&A history, and company performance, and then fill in the gaps of your quantitative research with qualitative data found within the four main content sets in the platform — company documents, news/regulatory documents, analyst research, and expert calls.
Our Generative Search feature makes it faster and easier than ever to get instant answers about any disease landscape — simply ask your questions in natural language and get instant, citable answers sourced from the premium sources found in the AlphaSense platform.
Earnings Analysis
In addition to housing thousands of earnings call transcripts within the platform, AlphaSense accelerates and sharpens your earnings research with sentiment analysis and AI smart search technology.
Sentiment analysis helps uncover shifts in commentary on relevant companies and disease areas. Our smart search technology also surfaces emerging topics from industry leaders, topics of discussion by competitors and healthcare providers, and company KPIs — enabling you to get a full-scale understanding of the industry.
Our generative AI-powered Smart Summaries allow you to instantly glean earnings insights — reducing time spent on research during earnings season and allowing you to focus on higher-value tasks.
Trend Forecasting
AlphaSense’s AI technology understands each client’s specific needs and interests, and recommends critical data sets, market trends, and emerging companies that are important to know in order to make proactive drug pipeline decisions and commercial assessments. Our Trending Topics and customizable dashboards enable you to monitor the precise themes and companies that are of most interest and value to your strategic goals, whether that be competitor documents, earnings calls, or expert sentiment. Our Generative Search feature is also highly effective for deep analysis of market evolution and future outlooks.
For example, you can ask: “How will advancements in AI and genomics shape personalized healthcare, what market challenges must be overcome, and what’s the growth potential if those challenges are addressed?” In return, you will get a structured report with clear analysis of technological innovations, clinical adoption rates, regulatory pathways, market access barriers, and strategic market growth opportunities.
Pharmaceutical Insights From the AlphaSense Platform
The following are a list of key insights, collected with the help of the AlphaSense platform, on the pharmaceutical industry:
Largest Pharmaceutical Companies by Market Cap in 2025
We use the AlphaSense platform to pull a list of the largest 50 pharmaceutical companies listed on U.S. stock exchanges.
The Impact of Tariffs on Healthcare
In this post, we provide an outlook for how Trump’s tariffs are expected to impact the healthcare sector, and particularly, pharmaceuticals and medical devices.
Biotech and Pharma M&A: 2025 Outlook
We use the AlphaSense platform to provide an outlook for deal activity in the biotech and pharma spaces for 2025.
5 Pharma Industry Trends to Watch in 2025
We use the AlphaSense platform to uncover the top pharma industry trends for 2025, including AI in drug development, patent cliffs, and strategic M&A. `
The Booming Market of Biosimilars
In this post, we dive into the biggest disruptor in the biologics market—biosimilars—and analyze the outlook for this industry trend based on what industry executives and experts are saying.
How Artificial Intelligence is Transforming Drug Development
We dive into AlphaSense Expert Insights to get experts’ perspectives on AI-based drug development adoption and what to expect moving forward.
Competitive Intelligence in Healthcare: Tracking FDA Drug Approvals
Learn how to use the AlphaSense platform to uncover key information buried within documents provided by major global health regulators.
Former Competitor Believes the Biopharma Industry Will Be Significantly Disrupted by Tariffs With Smaller Generic Pharma Companies Going Out of Business and Shortages of Consumer Healthcare Products Likely
In this expert interview found in our Expert Insights library, the expert gives his perspective on the impact of tariffs on the biopharma supply chain, the capacity of big pharmas to reshore manufacturing, and an outlook for long-term effects of the tariffs.
Executive Director at Novartis Sees Need for Strategic Overhaul in Pharmaceutical Pricing and Contracting
In this expert interview found in our Expert Insights library, the expert discusses the challenges and uncertainties within the pharma industry, focusing on pricing schemes, net price agreements, rebate contracting, and duplicate discounts.
Former Officer at Senderra Rx Believes Niche Relationships and Roll-Up Strategies Are Key for Specialty Pharmacy Growth
In this expert interview found in our Expert Insights library, the expert posits that we will likely soon be seeing accelerated consolidation in specialty pharmacy, due to smaller players struggling to access limited distribution drugs without niche expertise or acquisition by larger entities.
Additional Resources
Generative AI in Healthcare
Learn about the recent promising developments of generative AI within the healthcare space and what experts are predicting for the future of this technology.
